Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the clinical utility of stool and blood methylation tests for detection of advanced mucosal neoplasia (AMN) and sessile serrated polyps (SSP).


Clinical Trial Description

By not only diagnosing colorectal cancer (CRC) at an early stage, but also removing precursor lesions (adenomas), colonoscopy with polypectomy reduces the risk of developing and dying from CRC. Approximately 90% of polyps are less than 10 mm and are easily removed by competent endoscopists. Laterally spreading lesions (LST) and sessile lesions of the colon, also known as advanced mucosal neoplasia (AMN) are underrecognised types of lesions that are more likely to progress to cancer. They include sessile serrated polyps (SSP), an emerging entity of flat polyps with malignant potential. Detection of hemoglobin (a component of blood) in stool is an established validated screening tool for CRC. Its specific role in the prediction of AMN, and particularly SSPs is yet to be defined. Blood tests measuring the level of tumour derived methylated deoxyribonucleic acid (DNA) in blood circulating have been demonstrated to have clinical utility for detection of CRC and AMN. A blood based CRC screening test has the potential to increase compliance. This study aims to determine the clinical utility of stool and blood methylation tests for detection of AMN and SSPs. Stool and blood will be obtained from consenting patients referred for endoscopic removal of known ANM and SSP (study arm) as well as from consenting patients scheduled for colonoscopy screening (control arm). The level of stool hemoglobin and methylated tumour derived DNA in circulation will be measured in the two study groups. Cutoff values will be generated to assess best predictive capability of high risk lesions based on these tests. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02476682
Study type Observational
Source Western Sydney Local Health District
Contact
Status Completed
Phase
Start date January 11, 2016
Completion date July 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05954949 - Detection of Ileoanal Pouch/Reservoir Adenomas
Completed NCT03647176 - A Comparison of the Resection Rate of Cold Snare Polypectomy for Large (10-15 mm) and Small (5-9 mm) Colorectal Polyps N/A
Not yet recruiting NCT01214031 - Prospective Study for Evaluating Colon Polyp Histology With in Vivo Probe Based Confocal Laser Endomicroscopy N/A
Completed NCT04287335 - Multitarget Stool FIT-DNA Study for Colorectal Cancer Early Screening in China
Completed NCT00432913 - Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa Phase 2/Phase 3
Completed NCT04195646 - Computer Aided Detection of Polyps During Colonoscopy Procedures N/A
Terminated NCT01476631 - Step Down Colon Cancer Risk N/A
Recruiting NCT02263144 - Resect and Discard Extension to FICE of NIcE Classification N/A
Completed NCT01224444 - Complete Histologic Resection of Adenomatous Polyps? N/A
Completed NCT05875584 - Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection
Completed NCT01638091 - Practice-Based Learning to Predict Polyp Histology at Colonoscopy N/A
Terminated NCT00865527 - Pilot Study of Colon Cancer Screening Tests N/A
Withdrawn NCT04964596 - Managing Colorectal Cancer Prevention Procedure Wait Lists During the COVID-19 Pandemic N/A
Terminated NCT00486512 - Chemoprevention of Colorectal Adenomas Phase 3
Completed NCT03197987 - Comparison of Two Devices During Colonoscopy N/A
Terminated NCT03220711 - Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon N/A
Completed NCT00966420 - Traction Assisted Polypectomy of the Intestine N/A
Terminated NCT00118989 - Curcumin for the Chemoprevention of Colorectal Cancer N/A
Recruiting NCT06220617 - Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
Completed NCT02374515 - Safety and Efficacy of Endocuff-assisted Colonoscopy for Adenoma Detection. N/A